Healthcare Services

Acute Kidney Injury Market Outlook Through 2030 With Analysis Of Industry Trends And Developments

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Acute Kidney Injury Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The acute kidney injury market has witnessed substantial growth in recent years. Its value is expected to ascend from $5.72 billion in 2025 to $6.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion can be ascribed to several factors, including restricted access to sophisticated renal treatment, an increasing occurrence of co-existing conditions like diabetes and hypertension, an expansion in hospital facilities, the implementation of established dialysis procedures, and heightened understanding regarding AKI-related issues.

The acute kidney injury market is projected to experience substantial expansion in the coming years. It is anticipated to reach $7.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period is propelled by advancements in renal replacement therapies, the creation of new nephroprotective medications, an increase in ambulatory surgical centers, the growing application of biomarkers for early detection, and the incorporation of AI-based monitoring systems into renal care. Key trends expected over this period involve the increasing adoption of dialysis and various drug therapies, a global rise in the incidence of acute kidney injury, a heightened emphasis on early diagnosis and biomarker development, the broadening applications of urinary implants, and the incorporation of minimally invasive techniques in AKI management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

What Major Growth Factors Are Impacting The Acute Kidney Injury Market?

The increasing prevalence of diabetes is anticipated to propel the growth of the acute kidney injury market going forward. Diabetes refers to a group of metabolic diseases characterized by high blood sugar levels, stemming either from the body’s inability to produce sufficient insulin or from cells not responding properly to insulin. The rising prevalence of diabetes is driven by factors such as escalating obesity rates, poor diets, sedentary lifestyles, aging populations, and enhanced awareness and diagnosis. Acute kidney injury triggers metabolic and inflammatory changes that can influence insulin resistance and glucose homeostasis, highlighting a complex interplay that may impact diabetes progression and management. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the increased prevalence of diabetes is driving the growth of the acute kidney injury market.

What Segment Types Are Included In The Acute Kidney Injury Market Analysis?

The acute kidney injury market covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury

2) By Treatment Type: Renal Replacement Therapy (RRT), Pharmacological Management, Supportive and Conservative Management, Obstruction-Relief Interventions

3) By End User: Hospitals, Dialysis Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury

Which Trends Are Expected To Shape The Acute Kidney Injury Market?

Key companies active in the acute kidney injury (AKI) market are prioritizing the attainment of regulatory clearances to expand their product portfolios and introduce innovative treatment approaches. Regulatory approvals denote the formal authorization granted by supervisory bodies, such as the FDA or EMA, enabling a product to be marketed and sold after it meets established safety, efficacy, and quality criteria. For example, in December 2023, Mission Therapeutics Ltd., a UK-based biotechnology firm, secured FDA approval to launch a Phase II clinical trial for its lead compound, MTX652, intended for acute kidney injury (AKI) in patients at high risk following cardiac surgery. This compound is designed to target crucial pathways involved in kidney injury and repair, with the objectives of diminishing inflammation, preventing further kidney deterioration, and promoting recovery. A unique aspect of this trial is its emphasis on employing novel therapeutic mechanisms to address the core molecular causes of AKI, which could potentially offer more effective treatment alternatives compared to existing options. The Phase II trial will evaluate MTX652’s safety, effectiveness, and pharmacokinetics, furnishing critical data that could support wider clinical integration and prospective approval.

Who Are The Prominent Players Across The Acute Kidney Injury Market?

Major companies operating in the acute kidney injury market are Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Asahi Kasei Medical Co. Ltd., Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

Access The Complete Acute Kidney Injury Market Report:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

Which Geographic Region Represents The Largest Acute Kidney Injury Market Share?

North America was the largest region in the acute kidney injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Acute Kidney Injury Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Browse Through More Reports Similar to the Global Acute Kidney Injury Market 2026, By The Business Research Company

Kidney Dialysis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report

Acute Spinal Cord Injury Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Rare Kidney Diseases Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795